Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT04323488
Other study ID # 52231
Secondary ID
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date May 1, 2021
Est. completion date June 30, 2024

Study information

Verified date August 2021
Source Stanford University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Dyslexia, an impairment in accurate or fluent word recognition, is the most common learning disability affecting roughly ten percent of children. This proposal capitalizes on cutting edge neuroimaging methods, in combination with reading education programs, to generate a new understanding of how successful reading education shapes the development of the brain circuits that support skilled reading. A deeper understanding of the mechanisms of successful remediation of dyslexia, and individual differences in learning, will pave the way for personalized approaches to dyslexia treatment.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 40
Est. completion date June 30, 2024
Est. primary completion date June 30, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 8 Years to 12 Years
Eligibility Inclusion Criteria: - Reading difficulties defined as low scores on standardized measures of reading skills Exclusion Criteria: - no major contraindication for MRI (braces, metal implants, pacemakers, vascular stents, or metallic ear tubes). - Because the study involves measurements of reading and language ability, new recruits will be native English speakers. - Subjects have no history of neurological disorder, significant psychiatric problems - exclude claustrophobic subjects since an MRI might be uncomfortable for them.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Lindamood-Bell Seeing Stars
Seeing Stars in a curriculum developed by Lindamood-Bell. It is published and openly available. It involves systematic training in the building blocks of skilled reading.

Locations

Country Name City State
United States Stanford University Stanford California

Sponsors (1)

Lead Sponsor Collaborator
Stanford University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary White matter plasticity Change in white matter mean diffusivity measured with diffusion MRI Change between baseline (within 2 weeks pre-intervention) and post-intervention (within 2 weeks post-intervention)
Primary White matter plasticity Change in white matter mean diffusivity measured with diffusion MRI Change between baseline (within 2 weeks pre-intervention) and post-intervention (1 year follow-up)
See also
  Status Clinical Trial Phase
Completed NCT04028310 - Developmental Dyslexia and Remediation Methods N/A
Recruiting NCT04122820 - Ambulatory Screening for Specific Learning Disabilities (SLD) and Developmental Coordination Disorder (DCD). N/A
Recruiting NCT04287530 - Poly-unsaturated Fatty Acids and Developmental Dyslexia N/A
Completed NCT04041960 - Effects of TBS on Reading in Adult Struggling Readers N/A
Recruiting NCT06261307 - Language Development Deficits and Early Interactive Music Intervention N/A
Recruiting NCT05373576 - Neurofunctional Correlates of the Behavioral Modifications Associated With Tachidino in Children With Developmental Dyslexia N/A
Recruiting NCT06387615 - Impact of Non-invasive Brain Stimulation on Learning Novel Spoken Words N/A
Not yet recruiting NCT06403007 - Tackling Two of the Most Important Unresolved Tasks in Reading Intervention N/A